Summit Therapeutics Inc. Annual Depreciation in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Summit Therapeutics Inc. quarterly/annual Depreciation history and growth rate from 2017 to 2023.
  • Summit Therapeutics Inc. Depreciation for the quarter ending March 31, 2024 was $27K, a 70% decline year-over-year.
  • Summit Therapeutics Inc. annual Depreciation for 2023 was $198K, a 43.3% decline from 2022.
  • Summit Therapeutics Inc. annual Depreciation for 2022 was $349K, a 5.76% increase from 2021.
  • Summit Therapeutics Inc. annual Depreciation for 2021 was $330K, a 9.27% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $198K -$151K -43.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $349K +$19K +5.76% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $330K +$28K +9.27% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $302K -$19K -5.92% Jan 1, 2020 Dec 31, 2020 10-K/A 2022-12-21
2019 $321K -$88K -21.5% Feb 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $409K +$211K +107% Feb 1, 2018 Jan 31, 2019 10-K 2021-03-31
2017 $198K Feb 1, 2017 Jan 31, 2018 8-K 2020-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.